作者
Vidya Mahalmani, J Kumaravel, Manav Jain, Ajay Prakash, Bikash Medhi
发表日期
2021/5/1
来源
Indian journal of pharmacology
卷号
53
期号
3
页码范围
187-191
出版商
Medknow
简介
Coronavirus disease‑2019 (COVID‑19) has played a havoc that has had an enormous impact on social life, health, and economy worldwide. The World Health Organization, on June 1, 2020, addressed the danger of antimicrobial resistance (AMR)“one of the most urgent challenges of our time,” that is further made worse by this pandemic.[1]
COVID‑19 outbreak has masked longer‑term and major public health problems like the steady upsurge in AMR in the dark. However, one should not lose sight of existing problems that might possibly be aggravated by this pandemic. The pandemic lays emphasis on the need to take into consideration bacterial coinfections and other secondary infections during as well as subsequent to the viral outbreaks that have proven to be the most important cause of morbidity and mortality.
引用总数
学术搜索中的文章
V Mahalmani, J Kumaravel, M Jain, A Prakash… - Indian journal of pharmacology, 2021